Transmedics Group Inc buy BiotechBee
Start price
29.04.24
/
70%
€88.94
Target price
31.05.26
€130.00
Performance (%)
-30.63%
End price
14.12.24
€61.70
Summary
This prediction ended on 14.12.24 with a price of €61.70. Massive losses of -30.63% were the result for the BUY prediction by BiotechBee. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Transmedics Group Inc | -32.953% | -32.953% | -30.627% |
| iShares Core DAX® | 0,22 % | 1,49 % | 3,58 % |
| iShares Nasdaq 100 | 6,05 % | 16,19 % | 39,14 % |
| iShares Nikkei 225® | 5,72 % | 11,69 % | 50,96 % |
| iShares S&P 500 | 2,17 % | 8,06 % | 25,62 % |
According to BiotechBee what are the pros and cons of Transmedics Group Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Transmedics Group Inc diskutieren
Buy mit Kursziel 130,0